HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Clinical Trials

Download: Advancing Evidence Based Decision Making Toolkit

Listed as one of Evidence Soup's 5 Links of the week, this report describes in detail how researchers, policymakers, and program administrators can recognize opportunities for experiments and carry them out. Specifically, the report focuses on opportunistic experiments, defined as randomized […]

more info 11/18/2015View Related Articles
Bookmark and Share

Can Experimental Studies be More Like the Real World?

Clinical trials are great to prove effectiveness or safety, but what happens when real people in the real world are prescribed this medication? Does age make a difference? How about Comorbidities? Ultimately, we want to know what happens when the drug is used in routine clinical practice. The answer […]

more info 11/17/2015View Related Articles
Bookmark and Share

EMA Explains Exceptions to Trial Transparency

In another step towards increasing the availability of clinical trial data, the European Medicines Agency's management board has approved a set of rules on the submission and publication of information through the new EU clinical trials portal and database, which are expected to be up and running […]

more info 11/09/2015View Related Articles
Bookmark and Share

Check Out the New Issue of the Evidence Forum

The recent issue of the Evidence Forum includes a special interview: Establishing Health Technology Assessment in Russia: An Interview with Vitaly Omelyanovskiy. You can access this issue here, as well as archived issues. (Source: Evidera, October 2015) […]

more info 11/06/2015View Related Articles
Bookmark and Share

DaVita Celebrates 30 Years of Pioneering Research

DaVita Clinical Research is celebrating 30 of pioneering clinical research Take a look at their journey with these key milestones over the last 30 years here. (Source: MarketWatch, 9/29/15) […]

more info 10/14/2015View Related Articles
Bookmark and Share

What’s Next for Novartis?

dydforpharma Barcelona 2016 Keynote speaker David Epstein, CEO of Pharmaceuticals, Novartis sat down for an exclusive one-to-one in which he revealed what the future holds for Novartis. Find out more here. (Source: Paul Simms,  […]

more info 10/06/2015View Related Articles
Bookmark and Share

New Study Shows Intensive BP Management Could Save Your Life!

The U.S. National Institutes of Health recently released early findings from the Sprint Trial, a study of blood pressure management in people over 50. Does keeping systolic pressure below 120 reduce the cardiovascular disease and the risk of death? Find out here. (Source:  […]

more info 10/04/2015View Related Articles
Bookmark and Share

Mapi Responds to Growing Demand for eCOAs in Clinical Trials

Mapi Research Trust and CRF Health recently announced a collaboration to include eCOA solutions on PROQOLID. The growing demand for electronic clinical outcome assessments (eCOA) in clinical trials has created a significant need for this information. Read more here. (Source: PR Newswire, 9/8/15) […]

more info 09/21/2015View Related Articles
Bookmark and Share

Another Failed Product – What Will GSK Do Now?

With GlaxoSmithKline's megablockbuster Advair soon to be experiencing fierce generic competition, investors were assured that the pharma giant had another remedy in hand. Excitement built around Breo Ellipta, a drug developed to improve the mortality rate of high-risk patients with COPD, but the […]

more info 09/16/2015View Related Articles
Bookmark and Share

How Do Payers View Comparative Effectiveness and Relative Effectiveness Research?

A recently published paper in the International Journal of Technology Assessment in Health Care examined the views of payers in the United States and Europe on the rapidly evolving fields of comparative effectiveness and relative effectiveness research. See more here. (Source: OHE, 8/18/15) […]

more info 09/01/2015View Related Articles
Bookmark and Share

Clinical Trials – How Can You Predict Patient Interest?

Health Union recently analyzed its proprietary data to examine factors involved in patients' interest and participation in clinical research. Report available here. (Source: Nassim Azzi, eyeforpharma) […]

more info 08/28/2015View Related Articles
Bookmark and Share

Clinicaltrials.gov Leads to Frightening Discovery

A recent PLoS ONE study looking at reported clinical trial results, has shown a big change since the launch of the clinical trials.gov registry, with positive effect reports falling from 57% to a meager 8%. Read more here. (Source: Chris Woolston, nature.com, 8/13/15) […]

more info 08/17/2015View Related Articles
Bookmark and Share

Good Practices for Reporting Numerical and Statistical Results

Hey, Researchers! Leave Those Bars Alone! is a short infographic showing good practices for reporting numerical and statistical results. See here. (Source: Aspire Scientific Ltd, The Publication Plan, 7/29/15) […]

more info 07/29/2015View Related Articles
Bookmark and Share

Three Categories Influencing Clinical Trial Data Quality

 This article builds on a previous article discussing how to define clinical trial data quality, and elaborates on three categories impacting clinical trial data quality. Read more here. (Source: Applied Clinical Trials, 7/20/15) […]

more info 07/24/2015View Related Articles
Bookmark and Share

What Does the 21st Century Cures Mean for CROs?

Clinical Trials in the US are looking at a host of new provisions after a recent US House committee bill was passed. What impact will these provisions have on the way contract research organizations (CROs) operate? Find out here. (Source: Zachary Brennan, OutsourcingPharma.com, 6/17/15) […]

more info 07/15/2015View Related Articles
Bookmark and Share

Drugmakers to Start Using Apple’s ResearchKit in Clinical Trails

GlaxoSmithKline (GSK) and Purdue Pharma are reportedly looking to integrate Apple's ResearchKit in clinical trials. Learn more about how ResearchKit is being used, here. (Source: Katie Bell, FirstWord Pharma, 7/13/15) […]

more info 07/14/2015View Related Articles
Bookmark and Share

Big Data and the Effective Use of RWD are About to Transform R&D

RWDis useful in several phases of product development and is becoming crucial to decision making when used in conjunction with clinical trials.  (Source: PMLiVE, 6/26/15) […]

more info 06/30/2015View Related Articles
Bookmark and Share

Fraudulent Reports Dictating Worldwide Healthcare: How Big of a Problem is it?

Dr. Richard Horton, Editor-in-chief of the Lancet, recently published a statement declaring that a shocking amount of published research is unreliable at best, if not completely false, as in, fraudulent. Just how big of an issue is this really? The corruption of the medical industry worldwide is a […]

more info 06/29/2015View Related Articles
Bookmark and Share

Check Out PAREXEL’s New Monitoring Capabilities

PAREXEL International Corporation recently launched next generation risk-based monitoring capabilities, expanding its Perceptive MyTrials Data-Driven Monitoring (DDM) solution. What will these enhancements do for drug developers? Find out here. (Source: PAREXEL, 6/18/15) […]

more info 06/23/2015View Related Articles
Bookmark and Share

How do Policymakers View and Use CER?

Joel Weissman and colleagues recently had a study published in the Journal of Comparative Effectiveness Research. Their overarching question: How do senior coverage policymakers view and use CER? Find out what they learned and more here. (Source: AcademyHealth Blog, 6/15/15) […]

more info 06/22/2015View Related Articles
Bookmark and Share

PPD and HealthCore Collaborate to Enhance Research Services

Pharmaceutical Product Development LLC (PPD) and HealthCore Inc recently announced a collaboration, enabling both companies to further expand their services in the pre- and post-approval research market with the aim of helping biopharmaceutical clients demonstrate more quickly and cost effectively […]

more info 06/19/2015View Related Articles
Bookmark and Share

Why Are Drug Makers Hiding Reasons Behind Drug Rejections?

According to a new analysis, most pharmaceutical companies are not disclosing full details regarding FDA drug rejections - leaving patients and practitioners in the dark. Should pharmaceutical companies practice more transparency? Should the FDA change its regulations? Read more here. (Source: Ed […]

more info 06/18/2015View Related Articles
Bookmark and Share

Is Your Clinical Trial Designed for Commercial Success?

FirstWord's report, Clinical Trial Design for Commercial Success, offers expert insights on how to best position drugs for success through strategic innovative design of clinical trials, and give new drugs every advantage in the marketplace. Available for purchase here. (Source: FirstWord, 6/2015) […]

more info 06/17/2015View Related Articles
Bookmark and Share

CTI’s CEO Named Entrepreneur of the Year

CTI Clinical Trial and Consulting Services' CEO, Timothy Schroeder, was recently named EY Entrepreneur of the Year! Find out more about this prestigious award here! (Source: CTI, 6/16/15) […]

more info 06/16/2015View Related Articles
Bookmark and Share

ERT Acquisition of PHT Now Complete

ERT recently announced the completed acquisition of PHT, positioning ERT as the leader in eClinical Outcome Assessments (eCOA) and patient-centric data collection. Learn more here. (Source: ERT, 5/11/15) […]

more info 06/15/2015View Related Articles
Bookmark and Share

Patient Reported Outcomes – How Important is it to Use the Patient’s Own Words?

PatientsLikeMe has built its entire data scheme using patient-supplied symptoms, what they call the Patient Voice. This has helped tremendously to connect patients with one another, however it has proven to be quite a challenge when PatientsLikeMe, tried to use its data base to connect to the […]

more info 06/10/2015View Related Articles
Bookmark and Share

Meet inVentiv Health experts at DIA

We are a global provider of best-in-class clinical development and comprehensive commercialization services to the biopharmaceutical industry. Visit us at the event: booth #1517. […]

more info 06/08/2015View Related Articles
Bookmark and Share

Watson Group and Mayo Clinic – Matching Patients to Trials

Mayo Clinic and IBM's Watson group recently announced a collaboration to match Mayo oncology patients with the appropriate clinical trials. Read more here. (Source: Clinical Informatics News, 5/26/15) […]

more info 06/05/2015View Related Articles
Bookmark and Share

Can Financial Assistance Increase Participation in Clinical Trials?

A new study takes a look at financial barriers for many cancer patients participating in clinical trials, and how financial assistance affects enrollment. More here. (Source: Academy of Managed Care Pharmacy) […]

more info 06/03/2015View Related Articles
Bookmark and Share

How Big of a Game Changer is Immunotherapy for Cancer Care?

Researchers have long believed in the idea that the body's immune system had the potential to fight cancer, if only we could turn it against the disease. Today, some cancer patients are finding real success with immunotherapies, even after other treatments such as surgery, chemotherapy and radiation […]

more info 06/03/2015View Related Articles
Bookmark and Share

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Payers: The New Catalysts of Better Health
  • A writer’s role in drug development: a guide to getting started in regulatory medical writing
  • Virtual Medical Conferences: The new normal?
  • How Healthy Are Your Market Access Programs? ​​​​​​​A guide to performing check-ups on pharmaceutical distribution and patient access programs
  • The Overlooked Patient: How payers can identify, engage and treat the vulnerable populations not participating in their own care
  • Unlocking the potential of a Chief Outcomes Officer
  • Pharma’s path for digital health solutions
  • Gartner 2020 Magic Quadrant for Data Science + Machine Learning Platforms
  • How Are Changing Reimbursement Models Affecting Denials?
  • Regulation and Market Climate Force the Issue of CDM Prices
  • The Missing C-Suite Role
  • Patient- or Participant-Generated Registries
  • Multinational Registries: Challenges and Opportunities
  • Managing Missing Data in Patient Registries
  • Biorepositories
  • Increasing Focus on the Patient in Patient Registries
  • DIA DIRECT: Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator
  • Demonstrating the Value of Drugs for Rare Diseases – 8 Common Challenges and How to Address Them Before They Arise
  • How to Put AI + Predictive Analytics To Work
  • Insurance Design and Pharmaceutical Innovation
  • Global Biosimilars Pathways and Clinical Development Activity
  • Telemedicine adoption grew in most EU5 markets as COVID mitigation measures took hold
  • Mitigating COVID-19-related healthcare disruption
  • Marketing during COVID-19: A guide for pharma solution providers
  • State of Patient Centricity 2020: Advancing from Patient-first Intentions to True Co-creation
  • Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19
  • Bayesian Methodologies for COVID-19 Drugs, Devices and Biologics
  • Excellence In Payer Engagement: Strategic Outputs From A Roundtable Discussion
  • Evidence Generation and Communication: A Guide to Getting Started in HEOR/Market Access Medical Writing
  • Preparing for ICER assessments: key recommendations for manufacturers

Syndicated Reports

  • Pharmaceutical Payment System Market – Quantitative Analysis, Current and Future Trends, 2020 – 2027
  • The Future of Personalised Medicine: The Role of Simulation and Digital Twins
  • Medical Diagnostics: leveraging new opportunities from AI driven technology
  • Massive Growth in Digital Health Technology Market by Athenahealth, McKesson Corporation, Qualcomm, LifeWatch, AT & T, Cerner Corporation, Philips Healthcare, Cisco Systems
  • Real World Evidence: The Role of Medical Affairs
  • Pharmacy Benefit Management (PBM) – Industry Size 2019, Market Opportunities, Share Analysis up to 2025
  • Democrats and Drug Pricing
  • Global Health Economics & Outcomes Research (HEOR) Services Market Size, Share, Growth, Status and Forecast 2019-2025
  • Global Value-Based Reimbursement Software Market Size, Status and Forecast to 2026
  • Benchmarking Key Account Management Capabilities (2019)
  • The Future of Key Account Management in Pharma
  • Indication-level Pricing: Payer Insights
  • Real-World Data Capabilities: Benchmarking Pharma Companies (2019)
  • Success in Managed Markets: Payer Insights
  • Real World Data and Evidence: Payer Insights
  • KAM Metrics: Measuring Success (2019)
  • Biomarkers and Companion diagnostics: Payer Insights
  • Paying for Digital Health: Payer Insights (2019)
  • Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026
  • Biosimilars: US Payer Insights (2019)
  • Review of Influence: The Institute for Clinical and Economic Review
  • Innovative Drugs: Mapping the Pricing and Reimbursement Landscape
  • Orphan Drugs: European Payer Perspectives
  • Do Payers Really Want Pay-for-Performance?
  • Payer Engagement: Benchmarking Team Structure and Activity
  • Benchmarking Market Access Strategies for High-Cost Drugs and Biologics
  • Blockchain: Transformational Change for Pharma?
  • HTA in Europe: Key Success Factors for Positive HTA Recommendations
  • Paying for Digital Health: Payer Insights
  • Benchmarking Pharma’s MSL Capabilities
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute